Product Reports Resources Pricing Login Book a demo
Thomas Clozel
Person profile

Thomas Clozel

Super founder
9
Companies backed
4
Companies founded
$461M
Total funding raised
1 school
Education

Investments 9

Companies backed, as recorded by Dealroom. Highest company valuations first.

Resilience
Dioxycle
Norbert Health
1 recorded funding round · Latest in 2026
Altrove
1 recorded funding round · Latest in 2024
Grace-technology
1 recorded funding round · Latest in 2025
Osium AI
1 recorded funding round · Latest in 2023
Callyope
1 recorded funding round · Latest in 2023
kanji
Patch Biosciences

Companies founded

Currently

Active roles, board seats and partnerships.

Work history

Past roles by Dealroom records.

8400 - The Health Network
Global Expert · 2023
Fragment
Investor · 2023
Osium AI
Investor · 2023
Dioxycle
Investor · 2022
kanji
Investor · 2022
Spot
Investor · 2021
Resilience
Investor · 2021
Patch Biosciences
Investor · 2020
Hôpital Necker-Enfants Malades
2012 – 2014
Paris-Cité University
Master 2 Research Track · 2009 – 2010
Paris Diderot University - Paris City University
2009 – 2010
Weill Cornell Medicine
Research Fellow · 2009 – 2012
Assistance Publique - Hôpitaux de Paris
Intern · 2006 – 2012
Mount Sinai Medical Center
2004 – 2005
Mount Sinai Ventures
2004 – 2005

Education

Icahn School of Medicine at Mount Sinai
until 2006
← All people